• (no title)
    Search Engine Submission - AddMe
  • VISCERAL OBESITY
      Visceral obesity is associated with metabolic abnormalities that increase the risk of type 2 diabetes and CHD. Obese patients with a subst...
  • CARDIOMETABOLIC RISK FACTORS AND ITS INPUT ON CB1 RECEPTOR BLOCKAGE
    Rimonabant, the first selective CB (1) receptor antagonist in clinical use, has been extensively investigated in the Rimonabant in Obesity (...
  • TYPE 2 DIABETES
                                      THE TREATMENT OF METABOLIC ABNORMALITIES     Abdominal obesity is associated with numerous metaolic abno...
  • CARDIOMETABOLIC RISK FACTORS AND ITS IMPACT ON CB1 RECEPTOR BLOCKAGE
     Rimonabant, the first selective CB (1) receptor antagonist in clinical use, has been extensively investigated in the rimonabant in Obesity ...
  • LOOSE YOUR WEIGHT
    LOOSE YOUR WEIGHT           There are million of people across the world who are suffering from obesity that not only affects one's pers...
  • TYPE 2 DIABETES
       RELATIONSHIP BETWEEN CANNABINOID AND GLUCOSE METABOLISM       Cannabinoid 1 receptors have been identified not only in the brain, but a...
  • OBESITY CAUSES HYPERTENSION
    A relationship between obesity and high blood pressure is in fact, obese people have a higher blood pressure rather than people with a norma...
  • HAZARDS WITH OBESETY
         Obesity, especially visceral obesity, is associated with a cluster of metabolic complications increasing the risk of type 2 diabetes an...
  • HOW TO MANAGE TYPE 2 DIABETES, THE ENDOCANNABINOID SYSTEM
    Type 2 diabetes is closely related to abdominal obesity and is generally associated with cardiometabolic risk factor, resulting in a high in...